Showing results (1491-1500 of 2,533) with videos related to
Sort By:
Pageof 254
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 23, 2015
Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in Caucasian patientsM Radaelli, L Moiola, F Sangalli, et al.Journal of Contemporary Brachytherapy|November 22, 2019
Mould-based surface high-dose-rate brachytherapy for eyelid carcinomaAndrea Vavassori, Giulia Riva, Stefano Durante, et al.Drug and Alcohol Dependence|December 4, 2020
Prenatal Substance Exposure and Developmental Trajectories of Internalizing Symptoms: Toddlerhood to PreadolescenceMeeyoung O Min, Jeffrey M Albert, Noah Lorincz-Comi, et al.Medicine|December 9, 2016
A case report with the peculiar concomitance of 2 different genetic syndromesAlberto Lerario, Irene Colombo, Donatella Milani, et al.European Journal of Neurology|November 8, 2021
Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis with suboptimal response to prior disease-modifying therapies: A primary analysis from the phase 3b CASTING single-arm, open-label trialPatrick Vermersch, Celia Oreja-Guevara, Aksel Siva, et al.Frontiers in Neurology|March 8, 2021
Bilateral Repetitive Transcranial Magnetic Stimulation With the H-Coil in Parkinson's Disease: A Randomized, Sham-Controlled StudyFrancesca Spagnolo, Mario Fichera, Raffaella Chieffo, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|July 12, 2015
Abnormal cerebellar functional MRI connectivity in patients with paediatric multiple sclerosisSara Cirillo, Maria A Rocca, Angelo Ghezzi, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|May 8, 2007
Long-term follow-up of patients treated with glatiramer acetate: a multicentre, multinational extension of the European/Canadian double-blind, placebo-controlled, MRI-monitored trialM Rovaris, G Comi, M A Rocca, et al.Annals of Neurology|July 3, 2021
Spinal Fluid Myeloid Microvesicles Predict Disease Course in Multiple SclerosisStefano Gelibter, Marco Pisa, Tommaso Croese, et al.Neurorehabilitation and Neural Repair|August 17, 2011
Effectiveness of intensive inpatient rehabilitation treatment on disease progression in parkinsonian patients: a randomized controlled trial with 1-year follow-upGiuseppe Frazzitta, Gabriella Bertotti, Giulio Riboldazzi, et al.Pageof 254